NCT00027521View on ClinicalTrials.gov

Electroporation Therapy With Bleomycin in Treating Patients With Pancreatic Cancer

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

December 31, 2000

Conditions
Pancreatic Cancer
Interventions
BIOLOGICAL

bleomycin sulfate

DRUG

electroporation therapy

Sponsors
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Ichor Medical Systems Incorporated

INDUSTRY

NCT00027521 - Electroporation Therapy With Bleomycin in Treating Patients With Pancreatic Cancer | Biotech Hunter | Biotech Hunter